| Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease AG Fitzmaurice, SL Rhodes, A Lulla, NP Murphy, HA Lam, KC O’Donnell, ... Proceedings of the National Academy of Sciences 110 (2), 636-641, 2013 | 230 | 2013 |
| Roles of Pofut1 and O-fucose in mammalian Notch signaling M Stahl, K Uemura, C Ge, S Shi, Y Tashima, P Stanley Journal of Biological Chemistry 283 (20), 13638-13651, 2008 | 216 | 2008 |
| A novel “molecular tweezer” inhibitor of α-synuclein neurotoxicity in vitro and in vivo S Prabhudesai, S Sinha, A Attar, A Kotagiri, AG Fitzmaurice, ... Neurotherapeutics 9 (2), 464-476, 2012 | 195 | 2012 |
| Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity KC O’Donnell, A Lulla, MC Stahl, ND Wheat, JM Bronstein, A Sagasti Disease models & mechanisms 7 (5), 571-582, 2014 | 102 | 2014 |
| Neurotoxicity of the Parkinson's Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish Embryos BJM Lulla A, Barnhill L, Bitan G, Ivanova MI, Nguyen B, O'Donnell K, Stahl ... Environ Health Perspect, 2016 | 78 | 2016 |
| Positherapy: targeted nuclear therapy of breast cancer with 18F-2-deoxy-2-fluoro-D-glucose RM Moadel, RH Weldon, EB Katz, P Lu, J Mani, M Stahl, MD Blaufox, ... Cancer research 65 (3), 698-702, 2005 | 68 | 2005 |
| Canonical Notch signaling is dispensable for early cell fate specifications in mammals S Shi, M Stahl, L Lu, P Stanley Molecular and cellular biology 25 (21), 9503-9508, 2005 | 66 | 2005 |
| Notch1-induced transformation of RKE-1 cells requires up-regulation of cyclin D1 M Stahl, C Ge, S Shi, RG Pestell, P Stanley Cancer research 66 (15), 7562-7570, 2006 | 57 | 2006 |
| O-fucosylation of muscle agrin determines its ability to cluster acetylcholine receptors ML Kim, K Chandrasekharan, M Glass, S Shi, MC Stahl, B Kaspar, ... Molecular and Cellular Neuroscience 39 (3), 452-464, 2008 | 42 | 2008 |
| The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis M D’Amico, K Wu, D Di Vizio, AT Reutens, M Stahl, M Fu, C Albanese, ... Cancer research 63 (12), 3395-3402, 2003 | 33 | 2003 |
| Persistent Hemichorea and Caudate Atrophy in Untreated Diabetic Striatopathy: A Case Report EB Lucassen, WT Delfyett, MC Stahl Case Reports in Neurology 9 (3), 299-303, 2017 | 29 | 2017 |
| Capgras Syndrome in a Patient with Parkinson's Disease after Bilateral Subthalamic Nucleus Deep Brain Stimulation: A Case Report CR Kyrtsos, MC Stahl, P Eslinger, T Subramanian, EB Lucassen Case Reports in Neurology 7 (2), 127-133, 2015 | 22 | 2015 |
| H63D variant of the homeostatic iron regulator (HFE) gene alters α‐synuclein expression, aggregation, and toxicity Y Kim, MC Stahl, X Huang, JR Connor Journal of neurochemistry 155 (2), 177-190, 2020 | 12 | 2020 |
| Recurrent Episodes of Stroke-Like Symptoms in a Patient with Charcot-Marie-Tooth Neuropathy X Type 1 N Wu, S Said, S Sabat, M Wicklund, MC Stahl Case Reports in Neurology 7 (3), 247-252, 2015 | 8 | 2015 |
| P51 Phase 1/2 study to evaluate AOC 1020 for adult patients with facioscapulohumeral muscular dystrophy: FORTITUDE trial design A Halseth, E Ackermann, T Brandt, C Chen, H Cho, M Stahl, K DiTrapani, ... Neuromuscular Disorders 33, S71, 2023 | 2 | 2023 |
| DUX4 siRNA Optimization for the Development of an Antibody-Oligonucleotide Conjugate (AOC) for the Treatment of FSHD (P17-13.009) B Malecova, D Sala, GM Melikian, G Erdogan, R Johns, J Young, ... Neurology 98 (18 Supplement), 2022 | 1 | 2022 |
| Alpha-synuclein Protein Homeostasis and Oligomerization in Iron-overloaded Cells Expressing Mutant HFE (P3. 059) Y Kim, J Connor, M Stahl Neurology 90 (15 Supplement), 2018 | 1 | 2018 |
| Natural Products in Alzheimer's Disease: Impacts and Prospects SK Mishra, MC Stahl, P Singh Bioactive Natural Products: Opportunities and Challenges in Medicinal …, 2012 | 1 | 2012 |
| Phase 1/2 Trial Evaluating AOC 1044 in Healthy Volunteers and Participants with DMD Mutations Amenable to Exon 44 Skipping (DMD44): EXPLORE44 Trial Design (P4-8.007) M Stahl, E Ackermann, Y Zhu, Y Tami, S Hughes, C Laverty, C McDonald Neurology 102 (17_supplement_1), 2383, 2024 | | 2024 |
| VP396 More prevalent comorbidities, healthcare costs, and service utilization in male Myotonic Dystrophy (DM) patients and female patients J Day, K Munoz, C Chen, R Brook, N Kleinman, H Cho, B McEvoy, ... Neuromuscular Disorders 33, S157, 2023 | | 2023 |
Jeff Bronstein在 mednet.ucla.edu 的电子邮件经过验证
